CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 14 enrolled
Drug / intervention
Triferic +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02767128
NCT02767128Phase 1Completed
CompareCT.gov

Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol (Ferrous Sulfate) and Triferic (Ferric Pyrophosphate Citrate) Administered Orally With Shohl's Solution in Healthy Volunteers

Rockwell Medical Technologies, Inc.·interventional·Posted May 10, 2016·Updated Feb 1, 2019

In Brief

A Phase 1 clinical trial evaluating Triferic, Fer-In-Sol, and 1 other intervention for Iron-refractory, Iron-deficiency Anemia (IRIDA). Completed, enrolled 14 participants across 1 site.

Detailed Summary

The main purpose is to determine the pharmacokinetics (PK) of Triferic iron administered orally in healthy adult volunteers. It is a randomized multiple treatments, single dose study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIron-refractory, Iron-deficiency Anemia (IRIDA)
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 10, 2016
Enrollment StartApr 1, 2016
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 10.1 years ago

Interventions

Trifericdrug

Fer-In-Soldrug

Shohl's solutiondrug